ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000025638
Date of registration:	16/01/2017
Prospective Registration:	No
Primary sponsor:	Tokyo Metropolitan Institute of Gerontology
Public title:	Adenosine A2A receptors in Parkinson's disease
Scientific title:	Adenosine A2A receptors in Parkinson's disease - Adenosine A2A receptors in Parkinson's disease
Date of first enrolment:	2016/11/01
Target sample size:	40
Recruitment status:	Complete: follow-up complete
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029497
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Kenji Ishibashi
Address:	35-2, Sakae-cho, Itabashi-ku, Tokyo Japan
Telephone:	03-3964-3241
Email:	ishibashi@pet.tmig.or.jp
Affiliation:	Tokyo Metropolitan Institute of Gerontology Research Team for Neuroimaging

Name:	Kenji Ishibashi
Address:	35-2, Sakae-cho, Itabashi-ku, Tokyo Japan
Telephone:	03-3964-3241
Email:	ishibashi@pet.tmig.or.jp
Affiliation:	Tokyo Metropolitan Institute of Gerontology Research Team for Neuroimaging

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: 1. The subjects with a history of brain diseases, excluding than cerebellar diseases. 2. The subjects who are prescribed a medication for the central nervous system. 3. The subject who have chronic dysfunction in the organs. 4. Pregnant or woman who has a chance of pregnant. 5. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.

Age minimum: 40years-old
Age maximum: 89years-old
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Parkinson's disease

Intervention(s)

11C-preladenant-PET scanning

Primary Outcome(s)

Measurement of adenosine a2a receptor availability in Parkinson's disease

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Tokyo Metropolitan Institute of Gerontology

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.